| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/08/2007 | CA2616677A1 Cathepsin k inhibitors |
| 02/08/2007 | CA2616669A1 Squaric acid derivatives_ii |
| 02/08/2007 | CA2615666A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | CA2609441A1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/07/2007 | EP1749817A1 Neurogenic pain control agent composition |
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 02/07/2007 | EP1748982A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
| 02/07/2007 | EP1748783A2 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | CN1910174A Indolylmaleimide derivatives |
| 02/07/2007 | CN1910173A Indolylmaleimide derivatives as PKC inhibitors |
| 02/07/2007 | CN1910149A Bronchorelaxing compounds |
| 02/07/2007 | CN1910148A Indol-alanine derivatives as selective S1P4-agonists |
| 02/07/2007 | CN1910147A Malononitrile compound and use thereof |
| 02/07/2007 | CN1910141A Diamino alcohols and their use as renin inhibitors |
| 02/07/2007 | CN1909901A A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
| 02/07/2007 | CN1298722C Indole carbazole alkaloid and its preparing method and use |
| 02/07/2007 | CN1298721C Method of separating, large scale preparing porphyrin from complex reaction system |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/07/2007 | CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions |
| 02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298322C Crystalline solids of carvedilol and processes for their preparation |
| 02/06/2007 | US7173140 Process to form compound with indolocarbazole moieties |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
| 02/06/2007 | US7173059 Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds |
| 02/06/2007 | US7173058 For inhibiting PDE4(phosphodiesteases) in a mammal; of modulating the production of TNF- alpha; inhibiting matrix metalloproteinases, for therapy of undesired angiogenesis; therapy of cancer |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173045 Drugs for forming medicines such as analgesics formed by oximation and basification |
| 02/06/2007 | US7172907 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics |
| 02/06/2007 | CA2287262C Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 02/06/2007 | CA2192594C Preparation of .alpha.-methoxyiminocarboxylic acid methylamides and intermediates therfore |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013537A1 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance |
| 02/01/2007 | WO2007013201A1 Zinc fluorescent probe |
| 02/01/2007 | US20070027327 combining an isatin and ethylene glycol, reacting the solution with aqueous hydrazine and isolating the 2-oxindole; efficient route to preparing 2-oxindoles using inexpensive reagents, and simple purifications |
| 02/01/2007 | US20070027326 Process for the manufacture of an enantiopure compound |
| 02/01/2007 | US20070027202 Process for the preparation of carvedilol and its salts |
| 02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027112 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 01/31/2007 | EP1748681A1 Arylamine compound and organic electroluminescent device |
| 01/31/2007 | EP1748045A1 Light-emitting device material and light-emitting device |
| 01/31/2007 | EP1747774A1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres |
| 01/31/2007 | EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 01/31/2007 | CN1906200A Novel compounds |
| 01/31/2007 | CN1906161A N-sulfonyldicarboximide containing tethering compounds |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1905869A Indolinone based protein kinase inhibitors |
| 01/31/2007 | CN1903840A Process for preparing certain pyrrolotriazine compounds |
| 01/31/2007 | CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/30/2007 | US7169936 Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| 01/30/2007 | US7169935 Process for preparing heterocyclic indene analogs |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169829 Maleimido-bearing compounds resin composition containing the same and cured articles thereof |
| 01/30/2007 | US7169803 For therapy of disorders which are responsive to the opening of potassium channels, for therapy of ischemia, stroke, convulsions, epilepsy, asthma, irritable bowel syndrome, migraine, traumatic brain injury, elevated intracranial pressure, spinal cord injury, carbon monoxide poisoning, sexual dysfunction |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/25/2007 | WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| 01/25/2007 | WO2007010723A1 Tryptophan derivative and use thereof |
| 01/25/2007 | WO2007010504A2 Acid addition salts of isoindoles acting as adrenergic receptor antagonists |
| 01/25/2007 | WO2007010356A2 Process for the preparation of sulfonamide derivatives |
| 01/25/2007 | WO2007010044A1 3-indolylmethylene derivatives with cytostatic action |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006041874A3 Compounds for alzheimer's disease |
| 01/25/2007 | US20070021621 low non-specific binding, photostable, ease of chemical modification to permit tuning of absorption and emission wavelengths and resistance to the formation of dimers; 1-(5-carboxy-pentyl)-2-[5-(1-ethyl-3,3-dimethyl-5-phosphono-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3,3-dimethyl-3H-indolium |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021490 useful as synthetic intermediates to synthesize perindopril |
| 01/25/2007 | US20070021489 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 01/25/2007 | US20070021487 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070018569 which act as hole transporting and luminescent host materials for both fluorescent and phosphorescent emission |
| 01/24/2007 | EP1746087A1 Derivates of 3-indolylmethylene having cytostatic properties |
| 01/24/2007 | EP1745037A1 Indolylmaleimide derivatives as pkc inhibitors |
| 01/24/2007 | EP1745021A1 Hydroformylation process for pharmaceutical intermediate |
| 01/24/2007 | EP1745010A1 Substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1322710B1 Modified carbocyanine dyes and their conjugates |
| 01/24/2007 | CN1902205A Method for preparing phthalocyanines |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 01/24/2007 | CN1902174A Cis-alkoxyspiro-substituted tetramic acid derivatives |